PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Response to ASX Query, page-13

  1. 5,947 Posts.
    lightbulb Created with Sketch. 1138
    Yep, everything they've shown us is first and foremost attention to detail to pass fda requirements... probably to the detriment of this.... and to be honest, this is the company secretary's duties... not PR or anyone else in the medical or management team...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.